Flaviviral Protease Inhibitors Identified by Fragment-Based Library Docking into a Structure Generated by Molecular Dynamics

被引:55
作者
Ekonomiuk, Dariusz [1 ]
Su, Xun-Cheng [2 ]
Ozawa, Kiyoshi [2 ]
Bodenreider, Christophe [3 ]
Lim, Siew Pheng [3 ]
Otting, Gottfried [2 ]
Huang, Danzhi [1 ]
Caflisch, Amedeo [1 ]
机构
[1] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland
[2] Australian Natl Univ, Res Sch Chem, Canberra, ACT 0200, Australia
[3] Novartis Inst Trop Dis, Chromos, Singapore
关键词
VIRUS NS3 PROTEASE; ACCOMMODATING RECEPTOR FLEXIBILITY; ORBITAL ELECTRONEGATIVITY METHOD; MODIFIED PARTIAL EQUALIZATION; FLEXIBLE LIGAND DOCKING; DRUG DESIGN; SERINE-PROTEASE; IN-SILICO; DISCOVERY; BINDING;
D O I
10.1021/jm900448m
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Fragment-based docking was used to select a conformation for virtual screening from a molecular dynamics trajectory of the West Nile virus nonstructural 3 protease. This conformation was chosen from an ensemble of 100 molecular dynamics snapshots because it optimally accommodates benzene, the most common ring in known drugs, and two positively charged fragments (methylguanidinium and 2-phenylimidazoline). The latter fragments were used as probes because of the large number of hydrogen bond acceptors in the substrate binding site of the protease. Upon high-throughput docking of a diversity set of 18 694 molecules and pose filtering, only five compounds were chosen for experimental validation, and two of them are active in the low micromolar range in an enzymatic assay and a tryptophan fluorescence quenching assay. Evidence for specific binding to the protease active site is provided by nuclear magnetic resonance spectroscopy. The two inhibitors have different scaffolds (diphenylurea and diphenyl ester) and are promising lead candidates because they have a molecular weight of about 300 Da.
引用
收藏
页码:4860 / 4868
页数:9
相关论文
共 69 条
  • [1] Receptor flexibility in de novo ligand design and docking
    Alberts, IL
    Todorov, NP
    Dean, PM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (21) : 6585 - 6596
  • [2] Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold
    Aleshin, Alexander E.
    Shiryaev, Sergey A.
    Strongin, Alex Y.
    Liddington, Robert C.
    [J]. PROTEIN SCIENCE, 2007, 16 (05) : 795 - 806
  • [3] An improved relaxed complex scheme for receptor flexibility in computer-aided drug design
    Amaro, Rommie E.
    Baron, Riccardo
    McCammon, J. Andrew
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2008, 22 (09) : 693 - 705
  • [4] [Anonymous], W NIL VIR HOM
  • [5] Kinase-likeness and kinase-privileged fragments: Toward virtual polypharmacology
    Aronov, Alex M.
    McClain, Brian
    Moody, Cameron Stuver
    Murcko, Mark A.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (05) : 1214 - 1222
  • [6] Electrostatics of nanosystems: Application to microtubules and the ribosome
    Baker, NA
    Sept, D
    Joseph, S
    Holst, MJ
    McCammon, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) : 10037 - 10041
  • [7] Unveiling the full potential of flexible receptor docking using multiple crystallographic structures
    Barril, X
    Morley, SD
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (13) : 4432 - 4443
  • [8] The properties of known drugs .1. Molecular frameworks
    Bemis, GW
    Murcko, MA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (15) : 2887 - 2893
  • [9] Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs
    Bisson, W. H.
    Cheltsov, A. V.
    Bruey-Sedano, N.
    Lin, B.
    Chen, J.
    Goldberger, N.
    May, L. T.
    Christopoulos, A.
    Dalton, J. T.
    Sexton, P. M.
    Zhang, X.-K.
    Abagyan, R.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (29) : 11927 - 11932
  • [10] BODENREIDER C, IDENTIFICATION UNPUB